Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
Clinical trial NCT02581124 · COMPLETED
Trial details
- NCT number
- NCT02581124
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.